The Drugs Controller General of India (DCG(I)), India’s medical device and pharmaceutical market regulator, has appointed a new head of its Medical Device Division as well as a new Joint Drugs Controller, which could lead to more efficient registration processes in the country.

First, Aseem Sahu has been appointed head of DCG(I)’s Medical Device Division. In addition, Dr. V. G. Somani has been named Joint Drugs Controller at the Central Drugs Standard Control Organization’s head office in New Delhi.

These new DCG(I) appointments may cause short-term delays for Indian medical device market registrants, but will help boost transparency and predictability over the longer term for manufacturers.

Stewart Eisenhart